Flow mediated vasodilation and circulating concentrations of high sensitive C-reactive protein, interleukin-6 and tumor necrosis factor-α in normal pregnancy - The Cardiovascular Risk in Young Finns Study

Clinical Physiology and Functional Imaging

Volumn 29, Issue 5, 2009, Pages 347-352

  Saarelainen, Heli ^a   Valtonen, Pirjo ^a   Punnonen, Kari ^a   Laitinen, Tomi ^a   Raitakari, Olli T ^b   Juonala, Markus ^b   Heiskanen, Nonna ^a   Lyyra laitinen, Tiina ^a   Viikari, Jorma S A ^b   Heinonen, Seppo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cytokines; Endothelial function; Flow mediated vasodilation; High sensitive C reactive protein; Interleukin 6; Pregnancy; Tumor necrosis factor alpha;

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; BLOOD FLOW; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FINLAND; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERLEUKIN-6; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 69249146214     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2009.00877.x     Document Type: Article

References (26)

1. Belo L, Santos-Silva A, Rocha S, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, Rebelo I. "Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy". Eur J Obstet Gynecol Reprod Biol (2005); 123: 46-51.
2. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation (1997); 96: 3042-3047.
3. Bhagat K, Moss R, Collier J, Vallance P. "Endothelial "stunning" following a brief exposure to endotoxin: A mechanism to link infection and infarction?". Cardiovasc Res (1996); 32: 822-829.
4. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem (2004); 279: 48487-48490.
5. Celermajer DS. Endothelial dysfunction: Does it matter? is it reversible? J Am Coll Cardiol (1997); 30: 325-333.
6. Curry AE, Vogel I, Skogstrand K, Drews C, Schendel DE, Flanders WD, Hougaard DM, Thorsen P. Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors. J Reprod Immunol (2008); 77: 152-160.
7. Dorup I, Skajaa K, Sorensen KE. Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. Am J Physiol (1999); 276 (Pt 2): H821-H825.
8. Faber-Swensson AP, O'Callaghan SP, Walters WA. Endothelial cell function enhancement in a late normal human pregnancy. Aust N Z J Obstet Gynaecol (2004); 44: 525-529.
9. Hwang HS, Kwon JY, Kim MA, Park YW, Kim YH. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynecol Obstet (2007); 98: 105-109.
10. Jarvisalo MJ, Juonala M, Raitakari OT. Assessment of inflammatory markers and endothelial function. Curr Opin Clin Nutr Metab Care (2006); 9: 547-552.
11. Juonala M, Viikari JSA, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, Raitakari OT. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: The Cardiovascular Risk in Young Finns Study. Circulation (2004); 110: 2918-2923.
12. Kusanovic JP, Romero R, Hassan SS, Gotsch F, Edwin S, Chaiworapongsa T, Erez O, Mittal P, Mazaki-Tovi S, Soto E, Than NG, Friel LA, Yoon BH, Espinoza J. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J Matern Fetal Neonatal Med (2007); 20: 867-878.
13. Landmesser U, Hornig B, Drexler H. Endothelial function: A critical determinant in atherosclerosis? Circulation (2004); 109(Suppl. 1): II-27-II-33.
14. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: Application to clinical and public heAlth practice: a statement for healthcare professionals from the centers for disease control and prevention and the american heart association. Circulation (2003); 107: 499-511.
15. Raitakari M, Mansikkaniemi K, Marniemi J, Viikari JS, Raitakari OT. Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study. J Intern Med (2005); 258: 428-434.
16. Ridker PM. High-sensitivity c-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation (2001); 103: 1813-1818.
17. Saarelainen H, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, Viikari JS, Vanninen E, Heinonen S. Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J (2006); 70: 768-772.
18. Saarelainen H, Valtonen P, Punnonen K, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, Viikari JS, Vanninen E, Heinonen S. Subtle changes in ADMA and l-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation". Clin Physiol Funct Imaging (2008); 28: 120-124.
19. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol (2000); 47: 87-103.
20. Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science (2007); 317: 627-629.
21. Sierra-Laguado J, Garcia RG, López-Jaramillo P. Flow-mediated dilatation of the brachial artery in pregnancy. Int J Gynecol Obstet (2006); 93: 60-61.
22. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynecol Obstet (2001); 75: 243-249.
23. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: Does acute endothelial dysfunction provide a link? The Lancet (1997); 349: 1391-1392.
24. Watts DH, Krohn MA, Wener MH, Eschenbach DA. C-reactive protein in normal pregnancy. Obstet Gynecol (1991); 77: 176-180.
25. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today (1993); 14: 353-356.
26. Widlansky ME, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol (2003); 42: 1149-1160.